There are fools and there are stupids. Take your pick.josiejow37...

There are fools and there are stupids. Take your pick.

josiejow37 says "They received the $1.69 mil in Nov last year, deposited into their bank account. It relates to activities in FY23 and does not need to be 'backed out' or given back."

@smellyfingers is 100% correct. Not only you don't understand options but clearly you don't understand an Appendix 4C nor what the truth is.

Dec 2023 Quarterly Report
"On 14 November 2023, the Company advised that it had received the first tranche of its research and development tax incentive (RDTI) totalling $1.69 million"

So to get back to available cash at the end of March quarter @smellyfingers is correct. However, I would dispute the cash burn given that RHY has said that they have reduced costs significantly and bear in mind that the "trade and other payables" as at 31 December doesn't mean it must be paid in the March qtr. They could defer that payment until the next quarter. It is clearly monies still owing to Biotem.

It must be noted that RHY intended to raise $6.6 million in it's Rights Issue. They raised only $2.4 million. Oh, but I forgot they have 3 months to place the rest. LMAO...........Puh-lease!!!!!!! Miss josiejow37, I think you may be suffering from delirium.

Please tell me how many top 20 shareholders have supported the company in it's latest Rights issue.
It seems to me to be Otto Buttula and Sarah Cameron only. Yes, no?
I worked out that Otto took up $1,085,000 worth of shares.
Sarah Cameron took up just over $57,000 worth of shares.

Doctor Trevor Lockett took up his full entitlement (he held previously 1,291,000 shares) but was not previously on the 2023 Annual Report top 20 shareholders. He was allocated 387,300 shares and 193,650 options. Total investment $38,730.

The "Vom parties" bought jackshit.

So half of the rights issue supported by 3 top 20 shareholdetrs.

Great confidence?